Fusarium solani in the post-transplant patient: An unusual fungus

International Journal of Lower Extremity Wounds

Volumn 7, Issue 1, 2008, Pages 38-40

  Rekha, Arcot ^a,b   Kindo, Anupma J ^a   Ravi, Annamalai ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b Sukrithi   (India)

Author keywords

Fungi; Fusarium solani; Immunosuppressed; Transplantation

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; POSACONAZOLE; VORICONAZOLE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DOPPLER ECHOGRAPHY; FUNGUS CULTURE; FUSARIUM SOLANI; GRAFT INFECTION; GRAFT RECIPIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; MYCOSIS; PRIORITY JOURNAL;

AMPUTATION; DERMATOMYCOSES; FOOT ULCER; FUSARIUM; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 40549097770     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734607313879     Document Type: Article

References (14)

1. Singh N. Antifungal prophylaxis for solid organ transplant recipients. Clin Infect Dis. 2000 ; 31: 545-553.
2. Hadley S., Karchmer AW Fungal infections in solid organ transplant recipients. Infect Dis Clin North Am. 1995 ; 9: 1045-1074.
3. Hagerty JA, Ortiz J., Reich D., Manzarbeitia C. Fungal infections in solid organ transplant patients. Surg Infect (Larchmt). 2003 ; 4: 263-271.
4. Tollemar JG Fungal infections in solid organ transplant recipients. In: Bowden RA, Ljungman P, Paya VC, eds. Transplant Infections. New York, NY: Lippincott Raven; 1998: 339-350.
5. Known-Chung KJ, Bennet JE Medical mycology. In: Known-Chung KJ, Bennet JE, ed. Infections due to miscellaneous molds in Medical Mycology. 3 rd ed. Malvern, Philadelphia, PA: Lea and Febiger ; 1992: 733-767.
6. Singh N., Chang FY, Gayowski T., Marino IR Infections due to dematiaceous fungi in organ transplant recipients: case report and review. Clin Infect Dis. 1997 ; 24: 369-374.
7. Melcher GP, McGough DA, Fothergill AW, Norris C., Rinaldi MG Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme. J Clin Microbiol. 1993 ; 31: 1461-1467.
8. Summerbell RC, Richardson SE, Kane J. Fusarium proliferatum as an agent of disseminated infection in an immuno suppressed patient. J Clin Microbiol. 1988 ; 6: 82-87.
9. Mangini C., de Camargo B. Fungal infection due to fusarium (spp) in children with refractory hematologic malignancies. Med Pediatr Oncol. 1999 ; 32: 149-150.
10. Yildiran ST, Komurcu S., Saracli MA, et al. Fusarium fungaemia in severely neutropenic patients. Mycoses. 1998 ; 41: 467-469.
11. Makni F., Sellami H., Ayadi A., Elloumi M., Frikha M. Localized fusarium infections in acute myeloid leukemia. Rev Med Interne. 1999 ; 20: 447-448.
12. Helm TN, Longworth DL, Hall GS, Bolwell BJ, Fernandez B., Tomecki KJ Case report and review of resolved fusariosis. J Am Acad Dermatol. 1990 ; 23: 393-398.
13. Gandhi BV, Bahadur MM, Dodeja H., Aggrwal V., Thamba A., Mali M. Systemic fungal infections in renal diseases. J Postgrad Med. 2005 ; 51 (suppl 1). S30-36.
14. Girois SB, Chapuis F., Decullier E., Revol BG Adverse effects of antifungal therapies in invasive fungal infections: review and meta analysis. Eur J Clin Microbiol Infect Dis. 2005 ; 24: 119-130.